Adiponectin can activate AMPK in cell, suggesting that adiponectin may suppress tumor development through AMPK activation and subsequent inhibition of mammalian target of rapamycin (mTOR) (Barb D et al. 2007). The gene discussed is MTOR; the disease is neoplasm.